Orca Pharmaceuticals, New York University, Brickell Biotech deal

Orca and the university granted Brickell exclusive, worldwide rights to a series of preclinical small molecule RAR-related orphan receptor C ( RORC; RORgamma) inhibitors. Brickell will initially targ...